I am part of Athens LifeTech Park (ALTP), Greece’s first biotech & life sciences park. I focus on partnerships, connecting biotech startups, investors and pharma companies with ALTP’s infrastructure to support R&D scaling and collaboration.
Athens LifeTech Park (ALTP) is Greece’s first dedicated biotechnology and life sciences park, launching in Spata, Attica in 2026. Built around a biotech incubator and an integrated preclinical and early clinical CRO, ALTP offers a credible development environment where highly skilled scientists are genuinely engaged with your program, in one of Europe’s most cost-competitive environments, supporting programs from early discovery through translational development. We are actively seeking collaborations with venture-building VCs, pharma companies and start-ups — if this resonates, we would be glad to connect.
I am part of Athens LifeTech Park (ALTP), Greece’s first dedicated biotechnology and life sciences park. ALTP is built around a biotech incubator and an integrated preclinical and early clinical CRO, designed to support innovation from early discovery through translational development in a highly cost-competitive European environment.
In my role, I focus on partnerships and ecosystem development, working to connect biotech startups, venture-building investors, and pharmaceutical companies with ALTP’s infrastructure and capabilities. My work centers on fostering collaborations that accelerate life sciences innovation and support the successful development and scaling of R&D programs.
I am particularly interested in building strong cross-sector collaborations that bridge science, industry, and investment to advance impactful biotech solutions.
ALTP offers expert-led swine and minipig model services for preclinical drug development — one of Europe's most versatile and translationally relevant large animal platforms, in a cost-competitive EU-regulated environment.